.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Novartis
Covington
Express Scripts
Mallinckrodt
Deloitte
Teva
Dow
Boehringer Ingelheim

Generated: December 13, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: levomilnacipran hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2202-281 KIT in 1 BLISTER PACK (0456-2202-28)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2212-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2212-30)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2212-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2212-90)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2220-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2220-30)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2240-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2240-90)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2240-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2240-30)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2280-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2280-30)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAllergan USA, Inc.0456-2280-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2280-90)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168NDAAvera McKennan Hospital69189-2241-11 CAPSULE, EXTENDED RELEASE in 1 DOSE PACK (69189-2241-1)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Cipla
Merck
US Department of Justice
Healthtrust
Deloitte
Teva
Harvard Business School
Covington

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot